Cargando…

Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital

PURPOSE: Metagenomic next-generation sequencing (mNGS) is a powerful yet unbiased method to identify pathogens in suspected infections. However, little is known about its clinical effectiveness. The present study aimed to assess the efficacy of mNGS in routine clinical practice. PATIENTS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yang-Hua, Liu, Mei-Fang, Wu, Hongwen, Xu, De-Rong, Zhao, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066896/
https://www.ncbi.nlm.nih.gov/pubmed/37016633
http://dx.doi.org/10.2147/IDR.S401707
_version_ 1785018347815960576
author Xiao, Yang-Hua
Liu, Mei-Fang
Wu, Hongwen
Xu, De-Rong
Zhao, Rui
author_facet Xiao, Yang-Hua
Liu, Mei-Fang
Wu, Hongwen
Xu, De-Rong
Zhao, Rui
author_sort Xiao, Yang-Hua
collection PubMed
description PURPOSE: Metagenomic next-generation sequencing (mNGS) is a powerful yet unbiased method to identify pathogens in suspected infections. However, little is known about its clinical effectiveness. The present study aimed to assess the efficacy of mNGS in routine clinical practice. PATIENTS AND METHODS: In this single-center retrospective cohort study, 518 patients with suspected infectious diseases were assessed for inclusion. Among them, each patient had undergone mNGS testing; 407 patients had undergone both microbial culture and mNGS testing. The result of mNGS testing was compared to microbial culture performed concurrently. The diagnostic performance of mNGS was evaluated using the comprehensive clinical diagnosis as the reference standard. RESULTS: There was a significant difference in the positive detection rates of pathogens between mNGS and culture (331/407, 81.3% vs 79/407, 19.4%, P < 0.001). The sensitivity of mNGS was much higher than the culture method (79.5% vs 21.3%, P < 0.001), especially in sample types of sputum and bronchoalveolar lavage fluid (BALF). Notably, the sensitivity of blood mNGS was relatively lower than other sample types (67.4% vs 88.9–93.8%). Pathogen cfDNA load based on standardized stringently mapped read number at the species level of microorganisms (SDSMRN) was significantly lower in blood than in other sample types from the same patient (P = 0.0003). Importantly, mNGS directly led to a change of treatment regimen in 142 (27.4%) cases, including antibiotic escalation (15.3%), antibiotic de-escalation (9.1%), and early definitive diagnosis to initiate appropriate treatment (3.1%). CONCLUSION: Our in-house mNGS platform significantly improved the sensitivity for the diagnosis of infectious diseases. mNGS has the potential to improve clinical outcomes by optimizing antimicrobial therapy.
format Online
Article
Text
id pubmed-10066896
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100668962023-04-03 Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital Xiao, Yang-Hua Liu, Mei-Fang Wu, Hongwen Xu, De-Rong Zhao, Rui Infect Drug Resist Original Research PURPOSE: Metagenomic next-generation sequencing (mNGS) is a powerful yet unbiased method to identify pathogens in suspected infections. However, little is known about its clinical effectiveness. The present study aimed to assess the efficacy of mNGS in routine clinical practice. PATIENTS AND METHODS: In this single-center retrospective cohort study, 518 patients with suspected infectious diseases were assessed for inclusion. Among them, each patient had undergone mNGS testing; 407 patients had undergone both microbial culture and mNGS testing. The result of mNGS testing was compared to microbial culture performed concurrently. The diagnostic performance of mNGS was evaluated using the comprehensive clinical diagnosis as the reference standard. RESULTS: There was a significant difference in the positive detection rates of pathogens between mNGS and culture (331/407, 81.3% vs 79/407, 19.4%, P < 0.001). The sensitivity of mNGS was much higher than the culture method (79.5% vs 21.3%, P < 0.001), especially in sample types of sputum and bronchoalveolar lavage fluid (BALF). Notably, the sensitivity of blood mNGS was relatively lower than other sample types (67.4% vs 88.9–93.8%). Pathogen cfDNA load based on standardized stringently mapped read number at the species level of microorganisms (SDSMRN) was significantly lower in blood than in other sample types from the same patient (P = 0.0003). Importantly, mNGS directly led to a change of treatment regimen in 142 (27.4%) cases, including antibiotic escalation (15.3%), antibiotic de-escalation (9.1%), and early definitive diagnosis to initiate appropriate treatment (3.1%). CONCLUSION: Our in-house mNGS platform significantly improved the sensitivity for the diagnosis of infectious diseases. mNGS has the potential to improve clinical outcomes by optimizing antimicrobial therapy. Dove 2023-03-29 /pmc/articles/PMC10066896/ /pubmed/37016633 http://dx.doi.org/10.2147/IDR.S401707 Text en © 2023 Xiao et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Xiao, Yang-Hua
Liu, Mei-Fang
Wu, Hongwen
Xu, De-Rong
Zhao, Rui
Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital
title Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital
title_full Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital
title_fullStr Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital
title_full_unstemmed Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital
title_short Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital
title_sort clinical efficacy and diagnostic value of metagenomic next-generation sequencing for pathogen detection in patients with suspected infectious diseases: a retrospective study from a large tertiary hospital
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066896/
https://www.ncbi.nlm.nih.gov/pubmed/37016633
http://dx.doi.org/10.2147/IDR.S401707
work_keys_str_mv AT xiaoyanghua clinicalefficacyanddiagnosticvalueofmetagenomicnextgenerationsequencingforpathogendetectioninpatientswithsuspectedinfectiousdiseasesaretrospectivestudyfromalargetertiaryhospital
AT liumeifang clinicalefficacyanddiagnosticvalueofmetagenomicnextgenerationsequencingforpathogendetectioninpatientswithsuspectedinfectiousdiseasesaretrospectivestudyfromalargetertiaryhospital
AT wuhongwen clinicalefficacyanddiagnosticvalueofmetagenomicnextgenerationsequencingforpathogendetectioninpatientswithsuspectedinfectiousdiseasesaretrospectivestudyfromalargetertiaryhospital
AT xuderong clinicalefficacyanddiagnosticvalueofmetagenomicnextgenerationsequencingforpathogendetectioninpatientswithsuspectedinfectiousdiseasesaretrospectivestudyfromalargetertiaryhospital
AT zhaorui clinicalefficacyanddiagnosticvalueofmetagenomicnextgenerationsequencingforpathogendetectioninpatientswithsuspectedinfectiousdiseasesaretrospectivestudyfromalargetertiaryhospital